Wir sind mit live! Mehr erfahren
USPH-Symbol

US Physical Therapy

85,71 USD
-0,27
0,31 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
1 Tag
-0,31 %
5 Tage
1,71 %
1 Monat
2,78 %
3 Monate
15,53 %
6 Monate
9,63 %
Seit Jahresbeginn
8,66 %
1 Jahr
-4,23 %
5 Jahre
-18,23 %
10 Jahre
38,18 %
 

Profil: US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Mitarbeiter: 7.294

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 41,7 %
Neutral 50 %
Negativ 8,3 %
Neutral
Business Wire
vor 26 Tagen
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors (the “Board”) approved the appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026. Myra Davis currently serves as the Executive Vice President and Chief Information Innovation Officer at Texas Childr.
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
Positiv
MarketBeat
letzten Monat
U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
U.S. Physical Therapy NYSE: USPH is pursuing growth through clinic openings, acquisitions and a newer hospital-alliance strategy that Chief Executive Officer Chris Reading said could expand patient volumes and improve reimbursement.
U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
Neutral
Business Wire
letzten Monat
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chairman and Chief Executive Officer, presented at the 17th Annual Midwest Ideas Conference held on August 26, 2026. The presentation included a discussion of the overall operating environment in healthcare, the Company's key initiatives and a.
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
Neutral
Business Wire
vor 2 Monaten
U.S. Physical Therapy Announces CFO
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (“IIP”), today announced that Nchacha Etta will serve as the Company's Executive Vice President and Chief Financial Officer, effective as of September 1, 2026. Jason Curtis, the Company's Senior Vice President, Finance and Accounting, served as Interim CFO since April 24, 2026. M.
U.S. Physical Therapy Announces CFO
Positiv
MarketBeat
vor 2 Monaten
U.S. Physical Therapy Q2 Earnings Call Highlights
U.S. Physical Therapy NYSE: USPH reported second-quarter 2026 revenue growth supported by higher patient volumes, improved reimbursement rates and the early rollout of hospital-affiliation agreements, while elevated employee healthcare claims and upfront staffing costs pressured physical therapy margins.
U.S. Physical Therapy Q2 Earnings Call Highlights
Neutral
Seeking Alpha
vor 2 Monaten
U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript
Positiv
Seeking Alpha
vor 2 Monaten
U.S. Physical Therapy Continues To Heal
U.S. Physical Therapy, Inc. remains rated Hold as operational growth is offset by disappointing profitability and fair valuation. USPH exceeded revenue expectations in Q2 2026, but EPS fell short due to one-time events and rising costs. Clinic expansion, hospital affiliations, and industrial injury prevention services are driving top-line growth and future margin improvement.
U.S. Physical Therapy Continues To Heal
Negativ
Zacks Investment Research
vor 2 Monaten
U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.75 per share, missing the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.81 per share a year ago.
U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates
Positiv
Zacks Investment Research
vor 2 Monaten
U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for U.S. Physical Therapy (USPH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Neutral
Business Wire
vor 2 Monaten
USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (“IIP”), today reported results for the three and six months ended June 30, 2026. Total net revenue of $214.1 million for the second quarter ended June 30, 2026 (“Q2 2026”), an 8.5% increase over the second quarter ended June 30, 2025 (“Q2 2025”). Net income attributable to USPH.
USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance
Kursdiagramme mit Lightweight Charts™ umgesetzt